MNKD earnings: real EPS beat/miss history, analyst consensus Buy, P/E -49.68. Updated 2026-07-23.
MannKind (MNKD) Research Hub
MannKind (MNKD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.75 USD (-4.82%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -49.68, market cap 1.20B. This hub links to the full technical, earnings and options research available for MNKD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.75 USD (-4.82%) |
| 52-week range | 3.63 USD – 4.55 USD |
| Trend regime | Range |
| 14-day RSI | 41.7 (Bearish) |
| Trailing P/E | -49.68 |
| Market cap | 1.20B |
| Dividend yield | 0.00% |
Available research for MNKD
Covered Call on MNKD: how it works, illustrative setup around the real 3.75 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MNKD: how it works, illustrative setup around the real 3.75 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MNKD: how it works, illustrative setup around the real 3.75 USD price, max profit/loss, breakeven and when to use it. Educational.
MNKD technical analysis: range, last 3.75 USD, RSI 41.7, 52w range 3.63 USD–4.55 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MNKD in?
MannKind (MNKD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MNKD in an uptrend or downtrend?
As of 2026-09-11, MNKD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MNKD's trailing P/E ratio?
MNKD's trailing P/E is -49.68, with a market cap of 1.20B. See the earnings research page for full valuation detail.